Since miR-126 facilitates VEGF signaling by repressing SPRED1 and PIK3R2/p85-β, it has been suggested that low plasma miR-126 levels might have an impact on VEGF resistance and endothelial dysfunction in patients with T2DM (25). This evidence concerns the gene VEGFA and type 2 diabetes mellitus.